6 min. Read

Part 1: How one digital therapy got an NDC, and why it will be the last.

Issue 054.

Get E&O weekly. | Subscribe

Digital health research from Brian Dolan.

Welcome to E&O.

Last week I shared new financial details surrounding three recent M&A deals. Next week I'll write Part II of how a piece of software gets coded like a drug. Here's what's happening this week:

  • After a presentation on digital health business models to 100+ health startups in Finland, Sweden, and Iceland, I spent the rest of this week trying to wrap my head around NDC vs UDI coding. Read Part I: How Welldoc got an NDC code -- after the jump.
  • One of the newer prescription digital therapeutics companies I've been tracking (Issue 035) is IBS-focused Mahana Therapeutics. A new Medium post from the company reveals that Mahana's first product will be named Parallel: "Together, we’ve made major strides in a short amount of time. This includes the development of Parallel, Mahana’s first product,

Paying Subscribers Only

It's a good one, too.
This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!

Full access to E&O's research and newsletters.

Get the subscribers-only newsletters + research reports + databases
Facebook’s RCT for AI bot Zenny. More trials
7 min. Read
FDA de novo for Google smartphone thermometer.
6 min. Read
PDT-to-virtual-clinic trend continues. HCPCS tweaks.
8 min. Read
Mahana Tinnitus. New CPT hopefuls. Better cuts salaries
6 min. Read
CMS weighs HCPCS for Natural Cycles, Leva, and Tyto. Plus: Akili Q3 results.
8 min. Read
metaMe Health seeks buyer by year-end. CMS offers up digital therapeutics nothingburger
6 min. Read
PDT Pipeline changes. Kinsa shuts down. Trials
5 min. Read
CPT decisions. Trials: Big Health, Mahana and more
6 min. Read
Akili CEO steps down. Aetna rolls back some virtual care coverage
5 min. Read
Biogen cuts digital, MedRhythms, Apple. Pfizer on PDTs.
6 min. Read
  • First
  • Previous
  • 1 of 20
  • Next
  • Last